| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
IRD
Opus Genetics
|
May 21, 2026 | BUY |
Strong Buy
+154.9% avg upside
23 analysts
|
$10.00
155.43% Upside
|
-8.7% |
|
VYGR
Voyager Therapeutics
|
Dec 15, 2025 | BUY |
Strong Buy
+284.7% avg upside
23 analysts
|
$11.00
203.11% Upside
|
-19.7% |
|
ARCT
Arcturus Therapeutics
|
Oct 23, 2025 | BUY |
Buy
+291.8% avg upside
35 analysts
|
$17.00
131.89% Upside
|
-30.0% |
|
FR:ALSEN
Sensorion SAS
|
Sep 18, 2025 | BUY |
Strong Buy
+571.1% avg upside
5 analysts
|
$3.00
1090.50% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.